| Primary |
| Dyspnoea |
50.0% |
| Asthma |
25.0% |
| Bronchitis |
25.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
26.9% |
| Chronic Obstructive Pulmonary Disease |
19.7% |
| Drug Use For Unknown Indication |
7.2% |
| Asthma |
6.4% |
| Dermatitis |
4.8% |
| Thrombosis Prophylaxis |
4.8% |
| Epilepsy |
4.4% |
| Grand Mal Convulsion |
3.6% |
| Tachycardia Paroxysmal |
3.6% |
| Osteoporosis |
2.4% |
| Hypertension |
2.0% |
| Bronchitis |
1.6% |
| Conjunctivitis |
1.6% |
| Dyspnoea |
1.6% |
| Essential Hypertension |
1.6% |
| Nausea |
1.6% |
| Pruritus |
1.6% |
| Sleep Disorder |
1.6% |
| Vomiting |
1.6% |
| Atrial Fibrillation |
1.2% |
|
| Iron Deficiency Anaemia |
19.4% |
| Toxic Epidermal Necrolysis |
11.1% |
| Abdominal Pain Upper |
5.6% |
| Drug Ineffective |
5.6% |
| Fatigue |
5.6% |
| Haemorrhage |
5.6% |
| Nasal Dryness |
5.6% |
| Pneumonia |
5.6% |
| Sepsis |
5.6% |
| Apparent Death |
2.8% |
| Asthma |
2.8% |
| Cardiac Arrest |
2.8% |
| Cardiac Disorder |
2.8% |
| Convulsion |
2.8% |
| Dyspnoea |
2.8% |
| Gastric Ulcer |
2.8% |
| Hypotension |
2.8% |
| Nodule |
2.8% |
| Somnolence |
2.8% |
| Throat Irritation |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.6% |
| Asthma |
9.1% |
| Hypertension |
8.9% |
| Prophylaxis |
8.3% |
| Product Used For Unknown Indication |
7.7% |
| Chronic Obstructive Pulmonary Disease |
6.6% |
| Rheumatoid Arthritis |
4.6% |
| Bronchitis |
3.8% |
| Pain |
3.6% |
| Dyspnoea |
3.0% |
| Infection Prophylaxis |
3.0% |
| Insomnia |
2.8% |
| Non-small Cell Lung Cancer |
2.5% |
| Anxiety |
1.8% |
| Emphysema |
1.8% |
| Pneumonia |
1.8% |
| Depression |
1.6% |
| Crohn's Disease |
1.5% |
| Nausea |
1.5% |
| Chronic Lymphocytic Leukaemia |
1.4% |
|
| Emphysema |
7.9% |
| Pneumonia |
7.9% |
| Chronic Obstructive Pulmonary Disease |
6.3% |
| Crohn's Disease |
6.3% |
| Hyperkalaemia |
6.3% |
| Pneumothorax |
6.3% |
| Respiratory Failure |
6.3% |
| Iron Deficiency Anaemia |
4.8% |
| Pyrexia |
4.8% |
| Sudden Death |
4.8% |
| Asthma |
4.0% |
| Dementia Alzheimer's Type |
4.0% |
| Hypophosphataemia |
4.0% |
| Laryngeal Cancer |
4.0% |
| Malaise |
4.0% |
| Pseudomembranous Colitis |
4.0% |
| Respiratory Arrest |
4.0% |
| Speech Disorder |
4.0% |
| Cardiac Failure |
3.2% |
| Syncope |
3.2% |
|
